Home > Archive>Volume 52, Issue 2, 2025 >545-551. DOI:10.13344/j.microbiol.china.240745
PDF HTML XML Export Cite reminder
Research progress in bacterial ghost-based vaccines against bacterial zoonoses in animals
Author:
  • Article
    • | |
  • Metrics
    • |
  • Reference [43]
    • | | | |
  • Comments
    Abstract:

    Zoonoses pose a serious threat to human health and affect animal husbandry and public health security. Vaccination is an important means of preventing the spread of these diseases. As a novel type of candidate vaccines, bacterial ghost-based vaccines demonstrate broad application prospects because they can induce strong humoral, cellular, and mucosal immune responses. Moreover, they are praised for the simple fermentation production and purification processes and high safety. This paper briefs the preparation technology and immune response-triggering mechanism of bacterial ghosts and reviews the research progress of bacterial ghosts in brucellosis, a major bacterial zoonosis in animals, aiming to provide valuable reference for the development of novel vaccines.

    Reference
    [1] DONG XP, SOONG L. Emerging and re-emerging zoonoses are major and global challenges for public health[J]. Zoonoses, 2021. DOI: 10.15212/ZOONOSES-2021-0001.
    [2] ERKYIHUN GA, ALEMAYEHU MB. One health approach for the control of zoonotic diseases[J]. Zoonoses, 2022, 2(1): 963.
    [3] CARPENTER A, WALTENBURG MA, HALL A, KILE J, KILLERBY M, KNUST B, NEGRON M, NICHOLS M, WALLACE RM, BEHRAVESH CB, McQUISTON JH. Vaccine preventable zoonotic diseases: challenges and opportunities for public health progress[J]. Vaccines, 2022, 10(7): 993.
    [4] RAHMAN MT, SOBUR MA, ISLAM MS, IEVY S, HOSSAIN MJ, EL ZOWALATY ME, RAHMAN AT, ASHOUR HM. Zoonotic diseases: etiology, impact, and control[J]. Microorganisms, 2020, 8(9): 1405.
    [5] 孙浩杰, 任小侠, 秦玉明, 朱良全, 蒋卉, 孙石静, 丁家波, 辛凌翔, 王楠, 李晓宁, 李巧玲, 毛开荣, 蔡亚南, 徐磊. 一株粗糙型牛种布鲁氏菌诱导株的构建及鉴定[J]. 中国畜牧兽医, 2020, 47(11): 3445-3453. SUN HJ, REN XX, QIN YM, ZHU LQ, JIANG H, SUN SJ, DING JB, XIN LX, WANG N, LI XN, LI QL, MAO KR, CAI YN, XU L. Construction and identification of an induced strain of rough Brucella abortus[J]. China Animal Husbandry & Veterinary Medicine, 2020, 47(11): 3445-3453(in Chinese).
    [6] 朱良全, 丁家波, 秦玉明, 冯宇, 蒋卉, 彭小薇. 一种犬种布鲁氏菌单克隆抗体及其应用: CN202010827265.4[P]. 2022-02-01. ZHU LQ, DING JB, QIN YM, FENG Y, JIANG H, PENG XW. A monoclonal antibody to Brucella canines and its application: CN202010827265.4[P]. 2022-02-01(in Chinese).
    [7] 丁家波, 范学政, 朱良全, 冯宇, 彭小薇, 秦玉明, 王芳, 许冠龙, 李秋辰, 蒋卉. 一株重组鹦鹉热衣原体外膜蛋白MOMP基因的粗糙型布鲁氏菌及其疫苗生产方法: CN201910284652.5[P]. 2022-04-26. DING JB, FAN XZ, ZHU LQ, FENG Y, PENG XW, QIN YM, WANG F, XU GL, LI QC, JIANG H. A rough type Brucella strain with recombinant outer membrane protein MOMP gene from Chlamydia psittaci and its vaccine production method: CN201910284652.5[P]. 2022-04-26(in Chinese).
    [8] PARK SY. Chemically induced bacterial ghosts: a novel approach for advancing biomedical applications[J]. Molecular & Cellular Toxicology, 2023, 19(4): 657-665.
    [9] RABEA S, YASSIN AS, MOHAMMED AF, SALEM-BEKHIT MM, ALANAZI FK, ESMAIL EA, MONEIB NA, HASHEM AEM. Immunological characterization of the chemically prepared ghosts of Salmonella Typhimurium as a vaccine candidate[J]. BMC Veterinary Research, 2022, 18(1): 72.
    [10] HAN SW, SONG YF, WU XY, QU ZB, YU X, YANG X. Advances in bacteria-based drug delivery systems for anti-tumor therapy[J]. Clinical & Translational Immunology, 2024, 13(7): e1518.
    [11] LI XF, DONG HL, WANG HJ, HUANG XY, QIU YF, JI X, YE Q, LI CF, LIU Y, DENG YQ, JIANG T, CHENG G, ZHANG FC, DAVIDSON AD, SONG YJ, SHI PY, QIN CF. Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone[J]. Nature Communications, 2018, 9(1): 673.
    [12] HEIDARY M, DASHTBIN S, GHANAVATI R, MAHDIZADE ARI M, BOSTANGHADIRI N, DARBANDI A, NAVIDIFAR T, TALEBI M. Evaluation of brucellosis vaccines: a comprehensive review[J]. Frontiers in Veterinary Science, 2022, 9: 925773.
    [13] 刘晨芳, 翟景波, 梁晨, 德恩金, 张国庆, 王立军, 梁秀文. 布鲁氏菌病新型疫苗研究进展[J]. 中国人兽共患病学报, 2022, 38(12): 1141-1146. LIU CF, ZHAI JB, LIANG C, DE EJ, ZHANG GQ, WANG LJ, LIANG XW. Research progress in new brucellosis vaccine types[J]. Chinese Journal of Zoonoses, 2022, 38(12): 1141-1146(in Chinese).
    [14] MA Y, ZHU WJ, ZHU GS, XU Y, LI SY, CHEN R, CHEN LD, WANG JF. Efficient robust yield method for preparing bacterial ghosts by Escherichia coli phage ID52 lysis protein E[J]. Bioengineering, 2022, 9(7): 300.
    [15] BATAH AM, AHMAD TA. The development of ghost vaccines trials[J]. Expert Review of Vaccines, 2020, 19(6): 549-562.
    [16] CHEN HJ, JI H, KONG XJ, LEI PY, YANG QS, WU W, JIN LB, SUN D. Bacterial ghosts-based vaccine and drug delivery systems[J]. Pharmaceutics, 2021, 13(11): 1892.
    [17] WITTE A, WANNER G, BLÄSI U, HALFMANN G, SZOSTAK M, LUBITZ W. Endogenous transmembrane tunnel formation mediated by phi X174 lysis protein E[J]. Journal of Bacteriology, 1990, 172(7): 4109-4114.
    [18] MA Y, CUI L, WANG M, SUN QL, LIU KS, WANG JF. A novel and efficient high-yield method for preparing bacterial ghosts[J]. Toxins, 2021, 13(6): 420.
    [19] MEZHYROVA J, MARTIN J, PEETZ O, DÖTSCH V, MORGNER N, MA Y, BERNHARD F. Membrane insertion mechanism and molecular assembly of the bacteriophage lysis toxin ΦX174-E[J]. The FEBS Journal, 2021, 288(10): 3300-3316.
    [20] ORTA AK, RIERA N, LI YE, TANAKA S, YUN HG, KLAIC L, JR CLEMONS WM. The mechanism of the phage-encoded protein antibiotic from ΦX174[J]. Science, 2023, 381(6654): eadg9091.
    [21] ALI RH, ALI ME, SAMIR R. Production and characterization of bacterial ghost vaccine against Neisseria meningitidis[J]. Vaccines, 2022, 11(1): 37.
    [22] ABDELFATTAH A, SAMIR R, AMIN HM. Production of highly immunogenic and safe Triton X-100 produced bacterial ghost vaccine against Shigella flexneri 2b serotype[J]. Gut Pathogens, 2023, 15(1): 41.
    [23] AMARA AA, SALEM-BEKHIT MM, ALANAZI FK. Sponge-like: a new protocol for preparing bacterial ghosts[J]. The Scientific World Journal, 2013, 2013: 545741.
    [24] AARTHI Y, ANJANA A, TEJAL G, SHANMUGARAJA M, RAMADEVI S, PRINCESS R. A simple and rapid method of probiotic bacterial ghost cell preparation to deliver Mycobacterium tuberculosis antigen[J]. Molecular Biotechnology, 2024: 1-12.
    [25] CIESIELSKA A, MATYJEK M, KWIATKOWSKA K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling[J]. Cellular and Molecular Life Sciences, 2021, 78(4): 1233-1261.
    [26] XIE SZ, LI S, ZHANG ZL, CHEN MH, RAN P, LI XH. Bacterial ghosts for targeting delivery and subsequent responsive release of ciprofloxacin to destruct intracellular bacteria[J]. Chemical Engineering Journal, 2020, 399: 125700.
    [27] HAJAM IA, DAR PA, WON G, LEE JH. Bacterial ghosts as adjuvants: mechanisms and potential[J]. Veterinary Research, 2017, 48(1): 37.
    [28] DOBROVOLSKIENĖ N, PAŠUKONIENĖ V, DARINSKAS A, KRAŚKO JA, ŽILIONYTĖ K, MLYNSKA A, GUDLEVIČIENĖ Ž, MIŠEIKYTĖ-KAUBRIENĖ E, SCHIJNS V, LUBITZ W, KUDELA P, STRIOGA M. Tumor lysate-loaded bacterial ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines[J]. Vaccine, 2018, 36(29): 4171-4180.
    [29] YU HM, ZHOU XD, WEN S, XIAO Q. Flagellin/TLR5 responses induce mucus hypersecretion by activating EGFR via an epithelial cell signaling cascades[J]. Experimental Cell Research, 2012, 318(6): 723-731.
    [30] WEN JX, XUAN B, LIU Y, WANG LW, HE L, MENG XC, ZHOU T, WANG YM. Updating the NLRC4 inflammasome: from bacterial infections to autoimmunity and cancer[J]. Frontiers in Immunology, 2021, 12: 702527.
    [31] BUWITT-BECKMANN U, HEINE H, WIESMÜLLER KH, JUNG G, BROCK R, ULMER AJ. Lipopeptide structure determines TLR2 dependent cell activation level[J]. The FEBS Journal, 2005, 272(24): 6354-6364.
    [32] LIU J, LI Y, SUN Y, JI X, ZHU LW, GUO XJ, ZHOU W, ZHOU B, LIU S, ZHANG RA, FENG SZ. Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice[J]. Veterinary Immunology and Immunopathology, 2015, 166(3/4): 138-144.
    [33] KWON AJ, MOON JY, KIM WK, KIM S, HUR J. Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36(porcine myeloid antimicrobial peptide 36) in murine models[J]. The Journal of Veterinary Medical Science, 2016, 78(10): 1541-1548.
    [34] WANG SL, LI ZQ, ZHANG JL, XI L, CUI YY, ZHANG WHH, ZHANG JB, ZHANG H. A safe non-toxic Brucella abortus ghosts induce immune responses and confer protection in BALB/c mice[J]. Molecular Immunology, 2020, 124: 117-124.
    [35] HE CY, YANG JH, YE YB, ZHAO HL, LIU MZ, YANG QL, LIU BS, HE S, CHEN ZL. Proteomic and antibody profiles reveal antigenic composition and signatures of bacterial ghost vaccine of Brucella abortus A19[J]. Frontiers in Immunology, 2022, 13: 874871.
    [36] 贺笋, 刘梦志, 赵海龙, 吴冬玲, 刘宝山, 何传雨. 布鲁氏菌A19株菌影疫苗的构建及其免疫效果评价[J]. 中国兽医杂志, 2024, 60(5): 71-77. HE S, LIU MZ, ZHAO HL, WU DL, LIU BS, HE CY. Construction of Brucella A19 strain bacterial ghost vaccine and evaluation of its immune effect[J]. Chinese Journal of Veterinary Medicine, 2024, 60(5): 71-77(in Chinese).
    [37] SENEVIRATHNE A, HEWAWADUGE C, LEE JH. Immunization of chicken with flagellin adjuvanted Salmonella enteritidis bacterial ghosts confers complete protection against chicken salmonellosis[J]. Poultry Science, 2021, 100(7): 101205.
    [38] HALDER P, MAITI S, BANERJEE S, DAS S, DUTTA M, DUTTA S, KOLEY H. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: a prophylactic study in BALB/c mice[J]. Vaccine, 2023, 41(41): 5994-6007.
    [39] LI SY, WANG D, GUO CY, TIAN MT, LIU Q, PAN ZH. Study on preparation of a Streptococcus suis ghost vaccine[J]. Microbial Pathogenesis, 2021, 154: 104865.
    [40] HU JG, ZUO JK, CHEN ZG, FU LX, LV XL, HU SJ, SHI XC, JING YW, WANG YL, WANG ZH, MI RS, HUANG Y, LIU DH, QI KZ, HAN XG. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate[J]. Veterinary Microbiology, 2019, 229: 48-58.
    [41] DENTOVSKAYA SV, VAGAISKAYA AS, PLATONOV ME, TRUNYAKOVA AS, KOTOV SA, KRASIL’NIKOVA EA, TITAREVA GM, MAZURINA EM, GAPEL’CHENKOVA TV, SHAIKHUTDINOVA RZ, IVANOV SA, KOMBAROVA TI, GERASIMOV VN, UVERSKY VN, ANISIMOV AP. Peptidoglycan-free bacterial ghosts confer enhanced protection against Yersinia pestis infection[J]. Vaccines, 2021, 10(1): 51.
    [42] CHEN NN, JIANG DJ, LIU Y, ZHANG ZC, ZHOU YL, ZHU ZB. Preparation of Escherichia coli ghost of anchoring bovine Pasteurella multocida OmpH and its immunoprotective effect[J]. BMC Veterinary Research, 2023, 19(1): 192.
    [43] 焦红梅, 郑文浩, 杨慧, 堵嘉诚, 刘夕珑, 周芳鸣, 成伟. 肠炎沙门菌菌影的制备及其作为疫苗载体的特性分析[J]. 中国病原生物学杂志, 2019, 14(3): 315-318, 322. JIAO HM, ZHENG WH, YANG H, DU JC, LIU XL, ZHOU FM, CHENG W. Preparation and immunological characterization of Salmonella enteritidis ghosts as a vaccine vector[J]. Journal of Pathogen Biology, 2019, 14(3): 315-318, 322(in Chinese).
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WANG Longxi, DONG Chenhui, YUE Huaining, WANG Haojie, WANG Xiaoge, XIN Lingxiang, ZHU Liangquan. Research progress in bacterial ghost-based vaccines against bacterial zoonoses in animals[J]. Microbiology China, 2025, 52(2): 545-551

Copy
Share
Article Metrics
  • Abstract:73
  • PDF: 130
  • HTML: 113
  • Cited by: 0
History
  • Received:August 30,2024
  • Adopted:October 15,2024
  • Online: February 22,2025
  • Published: February 20,2025
Article QR Code
  • WeChat ID
  • Mobile Terminal

Microbiology China ® 2025 All Rights Reserved